ed In Public Citizen Petition To Ban It

FOR IMMEDIATE RELEASE

CONTACT:Richard Price

202-789-1447

877-846-6324

RPrice@akerpartners.com

EXTENSIVE CLINICAL DATA SUPPORTING EPHEDRA SAFETY AND BENEFITS VIRTUALLY IGNORED BY PUBLIC CITIZEN STATEMENT FROM THE EPHEDRA EDUCATION COUNCIL IN RESPONSE TO TRADE ASSOCIATION LETTER TO FDA


One of the FDA draft guidances addresses the use of nucleic acid tests to "reduce the risk of transmission of HIV-1 and HCV." A second draft guidance outlined a modified lot-release specification on HBsAg assays for blood testing. FDA Guidance - Blood Testing FDA Guidance - Modified Lot-Release


/index.php?option=com_iwpfile&file=/dir_01/he2002_1416.pdf

gs

FOR IMMEDIATE RELEASE:

Thursday, April 11, 2002

CONTACT: Ken Johnson or Vikki Riley

202.225.5735

!!!Media Advisory!!!

Health Subcommittee to Hold Hearing

On Medicare Prescription Drugs

Washington (April 11) -- The House Energy and Commerce Subcommittee on Health has scheduled a hearing for next Wednesday (April 17 at 10:00 a.m. in room 2123 of the Rayburn House Office Building) entitled, "Creating a Medicare Prescription Drug Benefit: Assessing Efforts to Help America's Low-Income Seniors."


/index.php?option=com_iwpfile&file=/dir_01/he2002_1411.pdf

/index.php?option=com_iwpfile&file=/dir_01/he2002_1410.pdf

/index.php?option=com_iwpfile&file=/dir_01/he2002_1408.pdf

al

T02-17

April 10, 2002

Media Inquiries: 301-827-6242

Consumer Inquiries: 888-INFO-FDA

FDA WARNS SELLERS OF NICOTINE LOLLIPOPS & LIP BALM THAT THEIR PRODUCTS ARE ILLEGAL


/index.php?option=com_iwpfile&file=/dir_01/he2002_1409.pdf

/index.php?option=com_iwpfile&file=/dir_01/he2002_1406.pdf

Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.